Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

The biology of chronic myeloid leukemia.

Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.

N Engl J Med. 1999 Jul 15;341(3):164-72. Review. No abstract available.

PMID:
10403855
[PubMed - indexed for MEDLINE]
2.

Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.

Warmuth M, Danhauser-Riedl S, Hallek M.

Ann Hematol. 1999 Feb;78(2):49-64. Review.

PMID:
10089019
[PubMed - indexed for MEDLINE]
3.

Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia.

Daley GQ, Ben-Neriah Y.

Adv Cancer Res. 1991;57:151-84. Review. No abstract available.

PMID:
1950703
[PubMed - indexed for MEDLINE]
4.

Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation.

Melo JV, Deininger MW.

Hematol Oncol Clin North Am. 2004 Jun;18(3):545-68, vii-viii. Review.

PMID:
15271392
[PubMed - indexed for MEDLINE]
5.

Chronic myeloid leukemia from basics to bedside.

Thijsen S, Schuurhuis G, van Oostveen J, Ossenkoppele G.

Leukemia. 1999 Nov;13(11):1646-74. Review.

PMID:
10557038
[PubMed - indexed for MEDLINE]
6.

[Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies].

Sánchez Fayos J, Prieto E, Chica Gullón E.

Sangre (Barc). 1998 Apr;43(2):121-6. Review. Spanish. No abstract available.

PMID:
9656773
[PubMed - indexed for MEDLINE]
7.

[New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].

Matolcsy A.

Orv Hetil. 2004 Dec 26;145(52):2603-9. Review. Hungarian.

PMID:
15724695
[PubMed - indexed for MEDLINE]
8.

Biology of BCR-ABL.

Chopra R, Pu QQ, Elefanty AG.

Blood Rev. 1999 Dec;13(4):211-29. Review. No abstract available.

PMID:
10741897
[PubMed - indexed for MEDLINE]
9.

Malignant transformation by abl and BCR/ABL.

Van Etten RA.

Cancer Treat Res. 1992;63:167-92. Review. No abstract available.

PMID:
1363357
[PubMed - indexed for MEDLINE]
10.

[Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].

Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.

Tsitologiia. 2007;49(10):889-900. Russian.

PMID:
18074781
[PubMed - indexed for MEDLINE]
11.

Amplification of the BCR/ABL fusion gene clustered on a masked Philadelphia chromosome in a patient with myeloblastic crisis of chronic myelocytic leukemia.

Gargallo PM, Cuello MT, Aranguren PN, Larripa IB.

Cancer Genet Cytogenet. 2003 Jun;143(2):140-4.

PMID:
12781448
[PubMed - indexed for MEDLINE]
12.

Chronic myeloid leukemia--advances in biology and new approaches to treatment.

Goldman JM, Melo JV.

N Engl J Med. 2003 Oct 9;349(15):1451-64. Review. No abstract available.

PMID:
14534339
[PubMed - indexed for MEDLINE]
13.

Molecular mechanisms of transformation by the BCR-ABL oncogene.

Sattler M, Griffin JD.

Semin Hematol. 2003 Apr;40(2 Suppl 2):4-10. Review.

PMID:
12783368
[PubMed - indexed for MEDLINE]
14.

A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia.

Jørgensen HG, Holyoake TL.

Hematol Oncol. 2001 Sep;19(3):89-106. Review.

PMID:
11574931
[PubMed - indexed for MEDLINE]
15.

Mechanisms of transformation by the BCR/ABL oncogene.

Sattler M, Griffin JD.

Int J Hematol. 2001 Apr;73(3):278-91. Review.

PMID:
11345193
[PubMed - indexed for MEDLINE]
16.

Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients.

Guo JQ, Lian J, Glassman A, Talpaz M, Kantarjian H, Deisseroth AB, Arlinghaus RB.

Am J Clin Pathol. 1996 Oct;106(4):442-8.

PMID:
8853030
[PubMed - indexed for MEDLINE]
17.

[The Philadelphia chromosome: from the gene to therapeutic methods].

Pérez-Losada J, González-Sarmiento R, Sánchez-García I.

Sangre (Barc). 1998 Apr;43(2):127-35. Review. Spanish. No abstract available.

PMID:
9656774
[PubMed - indexed for MEDLINE]
18.

Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.

Morel F, Bris MJ, Herry A, Calvez GL, Marion V, Abgrall JF, Berthou C, Braekeleer MD.

Eur J Haematol. 2003 Apr;70(4):235-9.

PMID:
12656747
[PubMed - indexed for MEDLINE]
19.

Identification of BCR-ABL fusion on chromosome 9 by fluorescence in situ hybridization in two chronic myeloid leukemia cases.

Abruzzese E, Pettenati MJ, Cox K, Jackle B, Watts RG, Carroll AJ, Steuterman MC, Rao PN.

Cancer Genet Cytogenet. 1998 Sep;105(2):164-7. Review.

PMID:
9723035
[PubMed - indexed for MEDLINE]
20.

Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.

Zhang JG, Lin F, Chase A, Goldman JM, Cross NC.

Blood. 1996 Mar 15;87(6):2588-93.

PMID:
8630427
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk